Detalhe da pesquisa
1.
Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias.
Mol Cell Proteomics
; 22(10): 100629, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37557955
2.
Dynamics of synaptic damage in severe traumatic brain injury revealed by cerebrospinal fluid SNAP-25 and VILIP-1.
J Neurol Neurosurg Psychiatry
; 2024 Jun 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38825349
3.
Quantification of blood glial fibrillary acidic protein using a second-generation microfluidic assay. Validation and comparative analysis with two established assays.
Clin Chem Lab Med
; 2024 Feb 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38353147
4.
Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury.
Clin Chem Lab Med
; 62(2): 322-331, 2024 Jan 26.
Artigo
Inglês
| MEDLINE | ID: mdl-37702323
5.
Serum Beta-Synuclein Is Higher in Down Syndrome and Precedes Rise of pTau181.
Ann Neurol
; 92(1): 6-10, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35340050
6.
Cerebrospinal fluid ß-synuclein as a synaptic biomarker for preclinical Alzheimer's disease.
J Neurol Neurosurg Psychiatry
; 94(1): 83-86, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35944974
7.
Higher plasma ß-synuclein indicates early synaptic degeneration in Alzheimer's disease.
Alzheimers Dement
; 19(11): 5095-5102, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37186338
8.
Blood ß-synuclein is related to amyloid PET positivity in memory clinic patients.
Alzheimers Dement
; 19(11): 4896-4907, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37052206
9.
Relationship of serum beta-synuclein with blood biomarkers and brain atrophy.
Alzheimers Dement
; 19(4): 1358-1371, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36129098
10.
Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS.
J Neurol Neurosurg Psychiatry
; 93(1): 68-74, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34417339
11.
CSF levels of SNAP-25 are increased early in Creutzfeldt-Jakob and Alzheimer's disease.
J Neurol Neurosurg Psychiatry
; 2022 Aug 22.
Artigo
Inglês
| MEDLINE | ID: mdl-35995553
12.
Serum GFAP differentiates Alzheimer's disease from frontotemporal dementia and predicts MCI-to-dementia conversion.
J Neurol Neurosurg Psychiatry
; 2022 Apr 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35477892
13.
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers.
Mov Disord
; 37(4): 669-683, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35122299
14.
Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration.
J Neural Transm (Vienna)
; 129(2): 207-230, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34460014
15.
Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer's Disease.
Int J Mol Sci
; 23(13)2022 Jun 22.
Artigo
Inglês
| MEDLINE | ID: mdl-35805926
16.
Neurochemical Monitoring of Traumatic Brain Injury by the Combined Analysis of Plasma Beta-Synuclein, NfL, and GFAP in Polytraumatized Patients.
Int J Mol Sci
; 23(17)2022 Aug 25.
Artigo
Inglês
| MEDLINE | ID: mdl-36077033
17.
Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer's disease.
J Neurol Neurosurg Psychiatry
; 92(4): 349-356, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33380492
18.
Cerebrospinal Fluid Levels of Prodynorphin-Derived Peptides are Decreased in Huntington's Disease.
Mov Disord
; 36(2): 492-497, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33006791
19.
Targeted Mass Spectrometry Suggests Beta-Synuclein as Synaptic Blood Marker in Alzheimer's Disease.
J Proteome Res
; 19(3): 1310-1318, 2020 03 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32101007
20.
Intrathecal immunoglobulin M production: A promising high-risk marker in clinically isolated syndrome patients.
Ann Neurol
; 83(5): 1032-1036, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29665046